AJMC October 21, 2024
While treatment options are evolving cancer care and extending lifespans, there is still a lack of biomarkers in certain cancers that can help direct treatment or provide early detection.
New treatments have extended life spans in certain cancers, but there remains a need for biomarkers in some that can help identify the best therapy for a patient, said Susan Wescott, RPh, MBA, senior director of managed care pharmacy, Mayo Clinic.
This transcript has been lightly edited for clarity.
Transcript
What are some areas where biomarkers are desperately needed but haven’t been identified yet? How do outcomes in those disease states compare with diseases with identified biomarkers?
Cancer care has been evolving and we now have great treatment options for breast...
Today's Sponsors
Today's Sponsor